Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Interstitial Lung Disease
Chronic Obstructive Pulmonary Disease
Sarcoidosis, Pulmonary
Pulmonary Hypertension

Interventions

DRUG: Semaglutide Pen Injector

Sponsor

University of Pennsylvania